AI for Order Management in Pharma

An order lands overnight from a wholesaler through the portal. It is for a controlled product, and the quantity is larger than anything that account has taken in the past year. The ship-to is a depot the customer has used twice. The licence held on file for that address lapsed last month, and nobody saw it, because licences live in one system and orders live in another. By the time the queue is opened the pick is built and the load is planned.

Somebody now has to decide whether this order should be filled at all, and write down why.

That duty is what makes order management in pharma a different discipline. Elsewhere an order is a commercial document and the job is to turn it into a shipment quickly. Here, for controlled and monitored products, you have a legal obligation to examine it, and sometimes to refuse it and report it. Declining is not a service failure. Accepting an order you should have questioned is, and that is the one that surfaces in an inspection finding.

Refusal is an outcome, not a failure

Most order management software assumes an order wants to become a shipment and that anything stopping it is friction. Here that assumption is wrong, and it has shaped both the systems and the metrics on the desk.

So the first design requirement for AI near this work is that a hold is a proper outcome rather than an error state. Held, with the reason in plain words, the evidence attached, a named person able to release it and a record of what they saw. Success is not orders touched per hour, but whether every held order carries a reason a reviewer would accept, and every released one too.

Nobody here is employed to type the easy orders

Clean orders already flow automatically. An electronic order from an established customer, for an unrestricted product, against a current licence, posts without anyone looking. Automate capture and you speed up what was already fast.

The headcount sits in the tail. The licence that expired. The ship-to that does not match the entitlement on record. The quantity that broke a pattern. The product that went on allocation on Monday. The quarantine hold that landed after the pick was built. The amendment that matches no order. Each needs somebody who knows which rule applies and where the answer is kept.

Arriving by portal, by file, by inbox

Most volume arrives through the portal and through electronic data interchange, well formed. The rest does not. A hospital pharmacy attaches a requisition to an email, a specialty channel sends its own template, some accounts still fax, and an amendment arrives as a reply in a shared mailbox quoting the customer's reference rather than yours. An agent identifies the customer, the account and the order being amended, and where it cannot it holds the item and asks.

A licence covers a product class, an address and a date

The question at validation is not whether the customer is a customer. It is whether this licence covers this product class, at this delivery address, on this date. Those tests fail independently of each other.

One ordering group can hold a wholesale dealing authorisation, a controlled substances registration, site level registrations for each dispensing location and enrolment in a restricted distribution programme for a single product, each with its own scope and expiry. The honest build is unglamorous: reconcile every order line against licence and entitlement data for the specific ship-to, and hold mismatches with the reason stated in language a colleague can read out unaltered.

The register is older than the order

Licence and registry data is frequently stale. Extracts refresh on their own schedule, customers restructure, sites change ownership, and renewals sit in flight while the record still shows the old expiry. So an agent reconciling against it produces questions, not verdicts, and has to say when it cannot tell a lapsed licence from a lapsed file.

Judging a quantity against a history and a peer group

Suspicious order monitoring is usually implemented as a threshold, a poor instrument on its own. It flags ordinary growth and misses the pattern break that stayed underneath.

The judgement expected of you is comparative. The customer against its own history: frequency, product mix, seasonality, the step change since the last order, the product class that appeared for no clinical reason. And the customer against its peer group, accounts of similar type, size and catchment. Related accounts matter, since one group ordering modestly from several of your depots looks unremarkable at each.

The file a reviewer should start from

An agent should produce the review file, not the finding. Ordering history, peer comparison, the feature that broke and by how far, earlier holds and how they resolved, licence status, and the related accounts nobody would have thought to pull. The reviewer starts from evidence rather than an afternoon in a spreadsheet.

Deciding who goes without is not a sequencing problem

When supply is short the order book stops being a queue. Demand is not ranked by who pays most. In a serious shortage the decision has a committee behind it and a written rationale: continuity of therapy for patients mid course, sites with no alternative supply, clinical urgency, tender obligations.

An agent keeps the picture underneath that committee current: what is genuinely available by week, what is committed, what the open order book asks for, what each customer historically consumed. Then it does the part that consumes the most hours, explaining to every affected customer what they are getting, what they are not and why, every week the shortage lasts. The ranking stays human.

Temperature history and the shelf life a customer will accept

What may ship to whom is also governed by the cold chain and by remaining shelf life. A hospital contract requires a minimum remaining life at delivery, a tender sets a different one, and some customers refuse short dated stock outright. Lane and packaging rules compound it, since a product that ships to a destination in winter may not be shippable there in summer in the same configuration.

An agent checks available batches against the receiving customer's rule before the pick is built, and separates orders that cannot be filled from those needing a documented concession.

Serialisation, verification and the moment before dispatch

Serialised identifiers, aggregation and dispatch reporting are the last gate, and a failure there holds a load otherwise ready to leave. The causes are mundane: the pick does not match what the serialisation system holds, an identifier was already reported as dispatched, an aggregation does not match the pallet built. An agent compares the order, the pick and the serialisation record before loading and names the lines that will fail.

A hold that lands after the pick is built

Recalls, quarantine decisions and market actions arrive while orders against the affected batches are confirmed, picked, loaded, in transit and invoiced.

The work is propagation. Every order, line and shipment touching those batches has to be found across the order book and the dispatch records, sorted into what can still be stopped and what has already left, and turned into actions naming who to contact first. Returns sit on the same seam, since returned goods cannot re-enter saleable stock on a receipt alone.

Chargebacks arrive long after the lorry left

Weeks after dispatch the invoice and the order stop agreeing. A wholesaler claims a contract price for a sale to an entity whose eligibility you verify after the fact. The price condition may not have been loaded when the order shipped. Rebate terms change retroactively, and purchasing group membership changes without anyone telling the desk.

An agent reconciles the order, the dispatch, the price condition that applied and the eventual claim, and explains each gap rather than netting it off. That matters for accruals as much as for disputes.

Why this one shipped and that one did not

Every decision on this desk is an inspection artefact. Long afterwards somebody asks why this order shipped, why that one was held, who released it and on what basis. Today the answer is reconstructed from fragments: a ticket, an email thread, a spreadsheet nobody owns.

Better to write the narrative as the work happens: the data the decision rested on, the rule applied, what was set aside, the person who signed. Explanation belongs in the output rather than beside it. If an agent cannot state its reasoning in a sentence a reviewer accepts, the work is not finished.

Where AI fails here

The decision to decline and report a suspicious order is a regulated judgement owned by a named accountable person. A model should never be the final word. It assembles, compares and recommends. Somebody signs.

Allocation under shortage has ethical weight. Which hospital waits is not an optimisation problem, and a model ranking accounts by revenue returns a clean answer to the wrong question.

Batch release, quality decisions and anything touching product quality or patient safety sit with the qualified person and the quality system. That boundary has no partial version.

An adverse event or a product complaint mentioned inside an order communication has its own mandatory reporting route and its own clock. It must be detected and escalated, never answered. Set that escalation bar deliberately low and accept the false positives.

Because licence and registry data is often out of date, an agent reconciling against it should raise questions, not verdicts. Confident refusals on stale data are a real failure mode.

A validated system under change control cannot absorb a component that quietly changes behaviour. Model versions have to be pinned, prompt and model changes have to pass change control, regression evidence must exist on a held set of real cases, and rollback must be documented and tested. The governance work here is as substantial as the build, and much of what governs this desk has never been written down.

Where to start

Begin with licence and entitlement reconciliation across the open order book and the ship-to records. Ground truth exists, the output is a question list rather than a shipment decision, and you will learn how stale your entitlement data is. Review file assembly for suspicious orders is the sensible second step, since it hands reviewers evidence without touching their authority.

Write down before you build what the agent may read, what it may write back into a validated system, and which decisions always carry a human name. That list is short and firm: refusal and reporting, allocation between customers, release of any hold, any quality or safety question. Then test it against a period you have already closed, with the acceptance bar agreed beforehand.

If your order desk spends its week chasing licences and building review spreadsheets, describe the process to Adopt AI Partners at hello@adoptaipartners.com for an honest read on what is automatable and what is not.